Overview

Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women

Status:
Recruiting

Trial end date:
2021-06-01

Target enrollment:

Participant gender:

Summary

High ucOC may favor insulin release in lean hyperandrogenic women to compensate for impaired insulin sensitivity. Meformin is an insulin sensitizing agent will be given for these women trying to interfere with the pathophysiology of PCOS in these women as followed up by serum UC-OC levels.

Phase:

Phase 1

Details

Lead Sponsor:

Beni-Suef University

Collaborator:

Cairo University

Treatments:

Metformin
Vitamins